A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects

European Journal of Nutrition

Volumn 44, Issue 2, 2005, Pages 65-71

  Høie, Lars H ^a   Morgenstern, Eve C A ^b   Gruenwald, Joerg ^b   Graubaum, Hans Joachim ^c   Busch, Regina ^c   Lüder, Wolfgang ^d   Zunft, Hans Joachim F ^d,e  

^a Nutri Pharma ASA   (Norway)

^b Nutri Pharma GmbH   (Germany)

^c Phytopharm Research   (Germany)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Blood cholesterol; Cardiovascular disease; Nutritional supplements; Soy phospholipids; Soy protein

Indexed keywords

ABACOR; APOLIPOPROTEIN B; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SOYBEAN PROTEIN; SUPROSOY;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILK; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RISK FACTORS; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 15244353871     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-004-0492-0     Document Type: Article

References (43)

1. Riesen WF (1998) Fettstoffwechsel. In: Thomas L (ed) Labor und Diagnose. TH-Books Verlagsgesellschaft mbH, Frankfurt/Main, pp 171-190
2. Brönstrup A, Pietrzik K (1996) Bedeutung von Homocystein bei der Entstehung von Atherosklerose - ist eine Supplementierung von Vitaminen sinnvoll? Ernährungsumschau 43:80-87
3. Müller-Bohn T (1996) Atherosklerose-prophylaxe - Bericht zum Fortbildungskongress in Malente. DAZ 136: 2453-2458
4. Shepherd J, Cobbe SM, Ford I, et al. (1996) Prävention der KHK durch Pravastatin bei Männern mit Hypercholesterinämie. Münch Med Wschr 138:21-28
5. Glore SR, an Treeck D, Knehans AW, Guild M (1994) Soluble fiber and serum lipids: A literature review. J Am Diet Assoc 94:425-436
6. Peters P, Peters KM, Saborowski F, et al. (1990) Lipidsenkung mit Ballaststoffen. Akt Ernähr-Med 15:119-122
7. Messena M, Erdman JW Jr (eds) (1995) First international symposium on the role of soy in preventing and treating chronic disease. J Nutr 125(Suppl): 567s-808s
8. Sirtori CR, Lovati MR, Manzoni C, et al. (1998) Reductions of serum cholesterol by soy proteins: clinical experience and potential molecular mechanism. Nutr Metab Cardiovasc Dis 8:334-340
9. Tsai AC, Mott EL, Owen GM, Bennick MR, Lo GS, Steinke FH (1983) Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humans. Am J Clin Nutr 38:504-511
10. Tham DM, Gardner CD, Haskell WL (1998) Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 83:2223-2235
11. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282
12. Baum JA, Teng H, Erdman JW, et al. (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551
13. Wong WW, Smith EOB, Stuff JE, Hachey DL, Heird WC, Pownell HJ (1998) Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 68(Suppl):1385S-1389S
14. Grouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159: 2070-2076
15. Washburn S, Burke GL, Morgan T, Anthony M (1999) Effects of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13
16. Merz-Demlow BE, Duncan AM, Wangen KE, et al. (2000) Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71:1462-1469
17. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Hassler CM (2000) Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71:1077-1084
18. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233
19. Puska P, Korpelainen V, Hoie LH, Sksovlund E, Lahti E, Smerud KT (2002) Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial. Eur J Clin Nutr 56:352-357
20. Tonstad S, Smerud KT, Hoie L (2002) A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76:78-84
21. Greaves KA, Parks JS, Williams KJ, Wagner JD (1999) Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 129:1585-1592
22. Ni W, Yoshida S, Tsuda Y, Nagao K, Sato M, Imaizumi K (1999) Ethanol-extracted soy protein isolate results in elevation of serum cholesterol in exogenously hypercholesterolemic rats. Lipids 34:713-716
23. Wangen KE, Duncan AM, Xu X, Kurzer MS (2000) Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic post-menopausal women. Am J Clin Nutr 73:225-231
24. Lo GS, Goldberg AP, Lim A, Grundhauser JJ, Anderson C, Schonfeld G (1986) Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects. Atherosclerosis 62:239-248
25. Brown L, Rosner B, Willet WW, Sacks FM (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69:30-42
26. Dewailley P, Moulin S, Rouget JP, Sezille G, Jaillard J (1985) Effects of polyenylphosphatidyl choline on lipoproteins in patients with hypercholesterolemia. Med Welt 36:367-369
27. Ovesen L, Ebbesen K, Olesen ES (1985) The effects of oral soybean phospholipid on serum total cholesterol, plasma triglyceride, and serum high-density lipoprotein cholesterol concentrations in hyperlipidemia. J Parenter Enteral Nutr 9:716-719
28. Sirtori CR, Zucchi-Dentone C, Sirtori M, et al. (1985) Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab 29: 348-357
29. Kirsten R, Heintz B, Nelson K, et al. (1994) Polyenylphosphatidyl choline improves the lipoprotein profile in diabetic patients. Int J Clin Pharmacol Ther 32:53-56
30. Polichetti E, Diaconescu N, de la Porte PL, et al. (1996) Cholesterol-lowering effect of soybean lecithin in normolipidemic rats by stimulation of biliary lipid secretion. Br J Nutr 75:471-481
31. LeBlanc MJ, Gavino V, Perea A, Yousef IM, Lévy E, Tuchweber B (1998) The role of dietary choline in the beneficial effects of lecithin on the secretion of biliary lipids in rats. Biochim Biophys Acta 1393:223-234
32. Polichetti E, Janisson A, Lechène de la Porte P, et al. (2000) Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits - role of the hepato-biliary axis. Life Sci 67:2563-2576
33. Leopold F, Noack R (1993) Einfluss von Ballaststoffen auf den Lipidstoffwechsel. In: Schulze J, Bock W (eds) Aktuelle Aspekte der Ballaststoffforschung. Behr's-Verlag, Hamburg, pp 147-155
34. Ramsay IE, Yeo WW, Jackson PR (1991) Dietary reduction of serum cholesterol concentration: time to think again. BMJ 303:953-957
35. Law MR, Wald MJ, Thompson SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower the risk of ischaemic heart disease? Brit Med J 308:367-373
36. Forschungsverband DHP (ed, 1998) Die Deutsche Herz-Kreislauf- Präventions-studie. Verlag Hans Huber, Bern
37. Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K (1998) Prevention of coronary heart disease in clinical practice. Summary of Recommendations of the Second Task Force of European and other Societies on Coronary Prevention. Eur Heart J 19: 1434-1503
38. Wald NJ, Law M, Watt HC, et al. (1994) Apolipoproteins and ischemic heart disease: implications for screening. Lancet 343:75-79
39. Damascene NR, Gidlund MA, Goto H, Dias CT, Okawabata FS, Abdalla DS (2001) Casein and soy protein isolate in experimental atherosclerosis: influence on hyperlipidemia and lipoprotein oxidation. Ann Nutr Metab 45:38-46
40. Kesaniemi YA, Grundy SM (1986) Effects of dietary polyenylphosphatidylcholine on metabolism of cholesterol and triglycerides in hypertriglyceridemic patients. Am J Clin Nutr 43: 98-107
41. Blumenthal M (ed, 1998) The complete German Commission E monographs. American Botanical Council, Austin, Texas, pp 210-213
42. Gianazza E, Eberini I, Arnoldi A, Wait R, Sirtori CR (2003) A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J Nutr 133:9-14
43. th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, September 21-24:2003, Orlando, Florida, USA